NANOPATH
NANOPATH
Address:
Clifton Park, New York, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Investors List
More informations about "Nanopath"
Nanopath - Diagnostics for Women
Our vision is to develop novel diagnostic technologies to equitably improve human health. Nanopath is commercializing a first-in-class molecular diagnostic platform to enable scalable, point-of-care disease diagnosis. We are an …See details»
Nanopath - Crunchbase Company Profile & Funding
Aug 9, 2022 · Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.See details»
NanoPath
Our clients are a select group of cutting edge technology companies with limited time to execute unlimited ideas. Every project they give us demands intense focus and rapid iteration. If you …See details»
Technology - nanopath
Nanopath is an NIH- and NSF-backed company focused on developing novel diagnostics to improve patient health. Pioneering Point-Of-Care Diagnostics. Nanopath was founded with the vision of commercializing a first-in-class …See details»
Nanopath Company Profile 2024: Valuation, Funding & Investors
Operator of a molecular diagnostics company intended to improve the health of women by providing granular and clinically actionable information.See details»
Nanopath - LinkedIn
Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information …See details»
Nanopath - Crunchbase Company Profile & Funding
Nanopath is a bi-tech startup. Where is Nanopath's headquarters? Nanopath is located in Clifton Park, New York, United States. Who invested in Nanopath? Nanopath has 2 investors …See details»
Vision — Nanopath
We envision a future that empowers both patients and their providers through immediately actionable diagnostic results. We’re working to enable a new standard-of-care, one that addresses the complex underlying biology and is …See details»
Nanopath Secures $10 Million in Series A Funding to …
CAMBRIDGE, Mass., Aug. 9, 2022 /PRNewswire/ -- Nanopath Inc., a molecular diagnostics company enabling high-quality molecular testing in minutes, announced today that it has closed $10 million in...See details»
Nanopath is looking to drastically change medical …
Aug 10, 2022 · For co-founders Amogha Tadimety and Alison Burklund, the idea of starting Nanopath, a women-focused molecular diagnostic company, came from a need to create a company focused on women’s health...See details»
Nanopath Receives $4 Million in Grants from National Institutes of ...
CAMBRIDGE, Mass., May 21, 2024 /PRNewswire/ -- Nanopath Inc., a point-of-care diagnostics company enabling high-quality molecular testing in minutes, announced today that it was …See details»
Nanopath Secures $10 Million in Series A Funding to Develop and ...
Aug 9, 2022 · Nanopath seeks to address disparities in care for underserved populations, starting with women's health, by introducing a novel approach to molecular diagnostic testing that …See details»
Nanopath Completes $10 Million Series A Funding
Aug 10, 2022 · Nanopath has closed $10 million in Series A funding co-led by Norwest Venture Partners and the Medtech Convergence Fund, a SV Health Investors venture fund, with …See details»
Nanopath Secures $10M to Develop POC Diagnostics for …
Aug 16, 2022 · Nanopath will develop & commercialize a biosensing platform that aims to transform how women's pelvic & gynecologic infections are diagnosed.See details»
Nanopath - Funding, Financials, Valuation & Investors - Crunchbase
Aug 9, 2022 · Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.See details»
Alison Burklund - Forbes
Dec 7, 2023 · Alison Burklund is the cofounder and CTO of Nanopath. Nanopath creates diagnostics that test pelvic and gynecologic infections during a single visit, so treatment can …See details»
Women’s diagnostics startup Nanopath scores $10M for rapid …
Aug 15, 2022 · Nanopath, a women's health diagnostics startup, recently closed a $10 million in Series A funding round. The company will use the money to develop and commercialize its …See details»
Nanopath raises $10M to be a diagnostic platform for women
Aug 9, 2022 · One of those is in life sciences, which Dr. Amogha Tadimety and Dr. Alison Burklund realized while doing their Ph.D. research at Dartmouth’s Engineering School, leading …See details»
Nanopath Founder Talks Pandemic Innovation – Magnuson Center …
May 5, 2021 · Dr. Amogha Tadimety, Th'20, Co-Founder & CEO of Nanopath, opened the healthcare-focused round of the spring Dartmouth Entrepreneurs Forum with a fireside chat in …See details»
NanoPath - UiT
NanoPath, a BioTek 2021 project funded by the Research Council of Norway, aims to bridge that gap, providing optical resolution of 50-250 μm with higher throughput and lower cost than …See details»